Revised MRPs post GST rate reduction, effective 22nd September – Making healthcare more affordable. Learn More
Company
We are driven by three core values of quality, affordability and accessibility.
R&D & Innovation
With 6 cutting-edge R&D facilities, we pioneer breakthroughs like Dydrogesterone in pharmaceutical excellence.
Safety & Sustainability
We have adopted policies aimed at complying with legislative requirements and ensuring the safety of our employees and the personnel working at our facilities or under our management.
International
Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society.
Investor Center
Mankind Pharma Ltd
NSE: MANKIND
-
-
Careers
Mankind Pharma is not just a workplace; it's a frontier of innovation. Join us in leveraging science to shape a healthier Bharat.
Shop
Discover more of Mankind
Close
Formulation R&D

Adverse Event Reporting

Share Adverse Event Details
Patient, Product and Event Information



    Calendar



    Calendar




    Reporter Information





    Are you a Health Care Professional?

    May we contact you for more information about your report


    You may report Adverse Events Experience and/or special scenario reports (such as - Pregnancy/lactation/Overdose/Lack of efficacy/Misuse/Abuse/Medication Error etc.) to email ID-pvunit@mankindpharma.com

    Confidentiality : The patient’s identity is held in strict confidence and protected as per applicable data provacy guidelines/Laws of country. The company shall not disclose the reporter’s identity in response to a request from the public.

    Find Your Local Mankind Pharma Drug Safety Team

    E-mail: pvunit@mankindpharma.com

    E-mail: Dr.jobin@skypharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: alina@northlife.com

    E-mail: pvunit@mankindpharma.com

    E-mail: mfonseca@profonsa.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: Mira_l212@mail.ru

    E-mail: pvunit@mankindpharma.com

    E-mail: tina.patel@wessexpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: aswathi.mathew@capitalpharmacy.net

    E-mail: pvunit@mankindpharma.com

    E-mail: rrestrepo@grupodokka.com

    E-mail: pvunit@mankindpharma.com

    E-mail: Poonam.asrani@tlgpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: caryne.oyier@phillipstanzania.co.tz

    E-mail: pvunit@mankindpharma.com

    E-mail: ravinder.kumar3@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: julius.turyatunga@tatainternational.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: regulatory@karibupharma.org

    E-mail: pvunit@mankindpharma.com

    E-mail: mousa@al-hobail.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: Hq.wang@greenpine.com.cn

    E-mail: pvunit@mankindpharma.com

    E-mail: Eberth.Sarmiento@emcure.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pvunit@mankindpharma.com

    E-mail: pv@pharmaid.com

    E-mail: pvunit@mankindpharma.com

    E-mail: dildora.i@pharmex.co

    E-mail: aziza.qoraxojayeva@eurolifecare.uz

    E-mail: pvunit@mankindpharma.com

    Know more about us
    Home
    About Us
    R&D
    Quality